Should You Buy This Stock After It Skyrocketed by 33%?

It's a welcome sight for shareholders who haven't had much to rejoice about lately. What a difference a day can make. Until Aug. 8, shares of Doximity (DOCS 0.69%), a healthcare-focused networking platform, were in the red for the year. However, on Aug. 9, the company's stock skyrocketed by more than 33%, making its year-to-date performance better than that of the broader market. As investors might guess, Doximity's gains had something to do with its latest quarterly report, but even after this jump, shares ...